Stay updated with breaking news from Nova Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nicholas Company Inc. reduced its holdings in LivaNova PLC (NASDAQ:LIVN – Get Rating) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 161,903 shares of the company’s stock after selling 1,680 shares during the period. Nicholas Company Inc. […]
LivaNova PLC (NASDAQ:LIVN – Get Rating) has received a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among analysts […]
LivaNova (NASDAQ:LIVN – Get Rating) had its price objective boosted by analysts at Barclays from $45.00 to $51.00 in a research note issued on Monday, The Fly reports. Barclays‘s target price would suggest a potential upside of 9.11% from the company’s previous close. A number of other brokerages have also commented on LIVN. StockNews.com assumed […]
LivaNova (NASDAQ:LIVN – Get Rating) updated its FY23 earnings guidance on Wednesday. The company provided EPS guidance of $2.50-$2.70 for the period, compared to the consensus EPS estimate of $2.57. Analyst Ratings Changes LIVN has been the topic of a number of recent research reports. Barclays dropped their target price on LivaNova from $62.00 to […]
Endonovo Therapeutics (OTCMKTS:ENDV – Get Rating) and LivaNova (NASDAQ:LIVN – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership. Volatility and Risk Endonovo Therapeutics has a beta of 0.25, suggesting […]